These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6258825)

  • 21. Simple and Fast Gas-chromatography Mass Spectrometry Assay to Assess Delta 9-Tetrahydrocannabinol and Cannabidiol in Dogs Treated with Medical Cannabis for Canine Epilepsy.
    Rotolo MC; Graziano S; Pellegrini M; Corlazzoli D; Antinori L; Porcarelli L; Pichini S
    Curr Pharm Biotechnol; 2017; 18(10):821-827. PubMed ID: 29173160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The detection of tetrahydrocannabinol in blood: a comparative study.
    Bergman RA; Lukaszewski T; Wang SY
    J Anal Toxicol; 1981; 5(2):85-9. PubMed ID: 6264225
    [No Abstract]   [Full Text] [Related]  

  • 23. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS.
    Kemp PM; Abukhalaf IK; Manno JE; Manno BR; Alford DD; Abusada GA
    J Anal Toxicol; 1995 Sep; 19(5):285-91. PubMed ID: 7500614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats.
    Hutchings DE; Martin BR; Gamagaris Z; Miller N; Fico T
    Life Sci; 1989; 44(11):697-701. PubMed ID: 2538691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations.
    Huestis MA; Barnes A; Smith ML
    Clin Chem; 2005 Dec; 51(12):2289-95. PubMed ID: 16223887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of ∆-9-Tetrahydrocannabinol (THC), 11-hydroxy-THC, 11-nor-9-carboxy-THC and Cannabidiol in Human Plasma using Gas Chromatography-Tandem Mass Spectrometry.
    Andrenyak DM; Moody DE; Slawson MH; O'Leary DS; Haney M
    J Anal Toxicol; 2017 May; 41(4):277-288. PubMed ID: 28069869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined high-performance liquid chromatography and radioimmunoassay method for the analysis of delta 9-tetrahydrocannabinol metabolites in human urine.
    Williams PL; Moffat AC; King LJ
    J Chromatogr; 1979 Dec; 186():595-603. PubMed ID: 232708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous and sensitive LC-MS/MS determination of tetrahydrocannabinol and metabolites in human plasma.
    Ferreirós N; Labocha S; Walter C; Lötsch J; Geisslinger G
    Anal Bioanal Chem; 2013 Feb; 405(4):1399-406. PubMed ID: 23104316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of delta 9-tetrahydrocannabinol (THC) in whole blood samples from impaired motorists.
    Zimmerman EG; Yeager EP; Soares JR; Hollister LE; Reeve VC
    J Forensic Sci; 1983 Oct; 28(4):957-62. PubMed ID: 6313845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On-line SPE LC-MS/MS for the quantification of Δ9-tetrahydrocannabinol (THC) and its two major metabolites in human peripheral blood by liquid chromatography tandem mass spectrometry.
    König S; Aebi B; Lanz S; Gasser M; Weinmann W
    Anal Bioanal Chem; 2011 Apr; 400(1):9-16. PubMed ID: 21311875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC.
    Ménétrey A; Augsburger M; Favrat B; Pin MA; Rothuizen LE; Appenzeller M; Buclin T; Mangin P; Giroud C
    J Anal Toxicol; 2005; 29(5):327-38. PubMed ID: 16105257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of delta 9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in blood and plasma.
    Johnson JR; Jennison TA; Peat MA; Foltz RL
    J Anal Toxicol; 1984; 8(5):202-4. PubMed ID: 6094914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged apparent half-life of delta 1-tetrahydrocannabinol in plasma of chronic marijuana users.
    Johansson E; Agurell S; Hollister LE; Halldin MM
    J Pharm Pharmacol; 1988 May; 40(5):374-5. PubMed ID: 2899638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The analysis of delta9-tetrahydrocannabinol and metabolite in whole blood and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in urine using disposable pipette extraction with confirmation and quantification by gas chromatography-mass spectrometry.
    Schroeder JL; Marinetti LJ; Smith RK; Brewer WE; Clelland BL; Morgan SL
    J Anal Toxicol; 2008 Oct; 32(8):659-66. PubMed ID: 19007518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentrations of delta9-tetrahydrocannabinol and 11-nor-9-carboxytetrahydrocannabinol in blood and urine after passive exposure to Cannabis smoke in a coffee shop.
    Röhrich J; Schimmel I; Zörntlein S; Becker J; Drobnik S; Kaufmann T; Kuntz V; Urban R
    J Anal Toxicol; 2010 May; 34(4):196-203. PubMed ID: 20465865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temporal indication of marijuana use can be estimated from plasma and urine concentrations of delta9-tetrahydrocannabinol, 11-hydroxy-delta9-tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid.
    Manno JE; Manno BR; Kemp PM; Alford DD; Abukhalaf IK; McWilliams ME; Hagaman FN; Fitzgerald MJ
    J Anal Toxicol; 2001 Oct; 25(7):538-49. PubMed ID: 11599597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood.
    Moody DE; Rittenhouse LF; Monti KM
    J Anal Toxicol; 1992; 16(5):297-301. PubMed ID: 1338217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Δ(9) -tetrahydrocannabinol detection using DrugWipe5S(®) screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users.
    Wille SM; Di Fazio V; Toennes SW; van Wel JH; Ramaekers JG; Samyn N
    Drug Test Anal; 2015 Mar; 7(3):178-86. PubMed ID: 24753449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.
    ElSohly MA; Stanford DF; Harland EC; Hikal AH; Walker LA; Little TL; Rider JN; Jones AB
    J Pharm Sci; 1991 Oct; 80(10):942-5. PubMed ID: 1664466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.